Dr. Ammira Al-Shabeeb Akil
Principal Investigator, Genetics and Metabolic Disorders Program Lead, Head, Precision Medicine of Diabetes Prevention laboratory, SIDRA Medicine
Dr. Ammira Al-Shabeeb is a Principal Investigator and the head of Precision Medicine of Diabetes and Obesity research program at Sidra Medicine. She completed her PhD in molecular genetics from University of New South Wales (UNSW), Sydney, Australia. She also has an International Executive master’s in business administration from HEC-Paris. After her PhD., she conducted three postdoctoral fellowship programs in pediatric infectious diseases, myeloma cancer drug targeting and genetics of type 1 diabetes. She has gained broad experience in cellular and molecular genetics through her appointments at the School of Medicine, Children Hospital of Westmead and Centenary Institute of Cancer Medicine and cell Biology (University of Sydney); laboratory testing organs donors for blood borne viruses and school of Women’s and Children’s health (Prince of Wales Hospital and University of new South Wales).
Dr. Ammira started a new chapter of her career by moving to Qatar to work at Sidra Medicine in 2016. She started her research group in 2019 with strategic goal of developing a world class and internationally recognized research programs within diabetes and associated complications. Over the years of training and independent career, she has sustained a very high research profile with a career total competitive grant funding award of over $6 Million USD. She leads research in developing the Genetic Risk Scores for diabetes and its complications in addition to developing genomic newborn screening for type 1 diabetes programs.
